Title : Population pharmacokinetic and pharmacodynamic modeling of pegvisomant in asian and Western acromegaly patients.

Pub. Date : 2011 Dec

PMID : 21209237






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pegvisomant is a growth hormone (GH) receptor antagonist that normalizes insulin-like growth factor I (IGF-I) levels in patients with acromegaly. pegvisomant insulin like growth factor 1 Homo sapiens
2 Pegvisomant is a growth hormone (GH) receptor antagonist that normalizes insulin-like growth factor I (IGF-I) levels in patients with acromegaly. pegvisomant insulin like growth factor 1 Homo sapiens
3 Although the dose of pegvisomant is determined by the IGF-I level, the pharmacokinetic and pharmacodynamic (PK/PD) model for pegvisomant concentration and IGF-I reduction has not been established. pegvisomant insulin like growth factor 1 Homo sapiens
4 A sigmoid E(max) model adequately described the relationship between IGF-I and pegvisomant concentrations. pegvisomant insulin like growth factor 1 Homo sapiens